Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
35M
-
Shares change
-
-3.12M
-
Total reported value, excl. options
-
$205M
-
Value change
-
-$20.2M
-
Put/Call ratio
-
0.87
-
Number of buys
-
54
-
Number of sells
-
-54
-
Price
-
$5.85
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2024
148 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2024.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35M shares
of 55.2M outstanding shares and own 63.48% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.43M shares), ARMISTICE CAPITAL, LLC (5.2M shares), EcoR1 Capital, LLC (3.92M shares), VANGUARD GROUP INC (3.19M shares), FARALLON CAPITAL MANAGEMENT LLC (2.29M shares), DIMENSIONAL FUND ADVISORS LP (1.11M shares), GEODE CAPITAL MANAGEMENT, LLC (1.08M shares), Erste Asset Management GmbH (1.06M shares), GREAT POINT PARTNERS LLC (960K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (906K shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.